Transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access

Research output: Contribution to journalArticle

Abstract

Purpose: To evaluate the feasibility and the outcomes of transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access in patients with chronic kidney disease. Methods: A total of 50 transjugular treatments in 38 patients with arteriovenous fistulas or arteriovenous grafts from September 2011 to May 2015 were included in this study. Medical records and angiographies were retrospectively reviewed. Success rate, patency rate, procedure time, and complications including internal jugular vein stenosis were evaluated. Results: A total of 50 sessions of transjugular treatments were performed in 38 patients. There were 31 native arteriovenous fistulas including 10 immature cases and 19 arteriovenous grafts. Among the 50 cases, technical success was achieved in 45 and clinical success was achieved in 44; 37 cases (74%) with multiple stenotic sites were treated by the transjugular approach without placement of cross-sheaths. The mean time from puncture of the internal jugular vein to first fistulography was 10 min, and the mean total procedure time was 64 min. The primary patency rate at 6 months was 77%, while the secondary patency rate at 6 months was 97%. Perforation occurred in two cases during conventional percutaneous transluminal angioplasty after failure of the transjugular approach. One dissection occurred during the transjugular approach. There was no newly developed internal jugular vein stenosis during a mean follow-up period of 19.3 months. Conclusion: For the treatment of dysfunctional or immature hemodialysis access, the transjugular approach is a feasible and effective option that avoids injury to the graft or draining vein, especially in immature fistulas.

Original languageEnglish
JournalJournal of Vascular Access
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Renal Dialysis
Jugular Veins
Arteriovenous Fistula
Transplants
Pathologic Constriction
Therapeutics
Chronic Renal Insufficiency
Angioplasty
Punctures
Fistula
Medical Records
Dissection
Veins
Angiography
Wounds and Injuries

Keywords

  • Arteriovenous fistula
  • arteriovenous graft
  • central vein stenosis
  • internal jugular vein
  • percutaneous transluminal angioplasty

ASJC Scopus subject areas

  • Surgery
  • Nephrology

Cite this

@article{9c0ca193814f42f7880bd73295da187b,
title = "Transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access",
abstract = "Purpose: To evaluate the feasibility and the outcomes of transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access in patients with chronic kidney disease. Methods: A total of 50 transjugular treatments in 38 patients with arteriovenous fistulas or arteriovenous grafts from September 2011 to May 2015 were included in this study. Medical records and angiographies were retrospectively reviewed. Success rate, patency rate, procedure time, and complications including internal jugular vein stenosis were evaluated. Results: A total of 50 sessions of transjugular treatments were performed in 38 patients. There were 31 native arteriovenous fistulas including 10 immature cases and 19 arteriovenous grafts. Among the 50 cases, technical success was achieved in 45 and clinical success was achieved in 44; 37 cases (74{\%}) with multiple stenotic sites were treated by the transjugular approach without placement of cross-sheaths. The mean time from puncture of the internal jugular vein to first fistulography was 10 min, and the mean total procedure time was 64 min. The primary patency rate at 6 months was 77{\%}, while the secondary patency rate at 6 months was 97{\%}. Perforation occurred in two cases during conventional percutaneous transluminal angioplasty after failure of the transjugular approach. One dissection occurred during the transjugular approach. There was no newly developed internal jugular vein stenosis during a mean follow-up period of 19.3 months. Conclusion: For the treatment of dysfunctional or immature hemodialysis access, the transjugular approach is a feasible and effective option that avoids injury to the graft or draining vein, especially in immature fistulas.",
keywords = "Arteriovenous fistula, arteriovenous graft, central vein stenosis, internal jugular vein, percutaneous transluminal angioplasty",
author = "Kim, {Jin Ho} and Cho, {Sung Bum} and Kim, {Yun Hwan} and Chung, {Hwan Hoon} and Lee, {Seung Hwa} and Sung, {Deuk Jae}",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1129729818815327",
language = "English",
journal = "Journal of Vascular Access",
issn = "1129-7298",
publisher = "Wichtig Publishing",

}

TY - JOUR

T1 - Transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access

AU - Kim, Jin Ho

AU - Cho, Sung Bum

AU - Kim, Yun Hwan

AU - Chung, Hwan Hoon

AU - Lee, Seung Hwa

AU - Sung, Deuk Jae

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Purpose: To evaluate the feasibility and the outcomes of transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access in patients with chronic kidney disease. Methods: A total of 50 transjugular treatments in 38 patients with arteriovenous fistulas or arteriovenous grafts from September 2011 to May 2015 were included in this study. Medical records and angiographies were retrospectively reviewed. Success rate, patency rate, procedure time, and complications including internal jugular vein stenosis were evaluated. Results: A total of 50 sessions of transjugular treatments were performed in 38 patients. There were 31 native arteriovenous fistulas including 10 immature cases and 19 arteriovenous grafts. Among the 50 cases, technical success was achieved in 45 and clinical success was achieved in 44; 37 cases (74%) with multiple stenotic sites were treated by the transjugular approach without placement of cross-sheaths. The mean time from puncture of the internal jugular vein to first fistulography was 10 min, and the mean total procedure time was 64 min. The primary patency rate at 6 months was 77%, while the secondary patency rate at 6 months was 97%. Perforation occurred in two cases during conventional percutaneous transluminal angioplasty after failure of the transjugular approach. One dissection occurred during the transjugular approach. There was no newly developed internal jugular vein stenosis during a mean follow-up period of 19.3 months. Conclusion: For the treatment of dysfunctional or immature hemodialysis access, the transjugular approach is a feasible and effective option that avoids injury to the graft or draining vein, especially in immature fistulas.

AB - Purpose: To evaluate the feasibility and the outcomes of transjugular percutaneous endovascular treatment of dysfunctional hemodialysis access in patients with chronic kidney disease. Methods: A total of 50 transjugular treatments in 38 patients with arteriovenous fistulas or arteriovenous grafts from September 2011 to May 2015 were included in this study. Medical records and angiographies were retrospectively reviewed. Success rate, patency rate, procedure time, and complications including internal jugular vein stenosis were evaluated. Results: A total of 50 sessions of transjugular treatments were performed in 38 patients. There were 31 native arteriovenous fistulas including 10 immature cases and 19 arteriovenous grafts. Among the 50 cases, technical success was achieved in 45 and clinical success was achieved in 44; 37 cases (74%) with multiple stenotic sites were treated by the transjugular approach without placement of cross-sheaths. The mean time from puncture of the internal jugular vein to first fistulography was 10 min, and the mean total procedure time was 64 min. The primary patency rate at 6 months was 77%, while the secondary patency rate at 6 months was 97%. Perforation occurred in two cases during conventional percutaneous transluminal angioplasty after failure of the transjugular approach. One dissection occurred during the transjugular approach. There was no newly developed internal jugular vein stenosis during a mean follow-up period of 19.3 months. Conclusion: For the treatment of dysfunctional or immature hemodialysis access, the transjugular approach is a feasible and effective option that avoids injury to the graft or draining vein, especially in immature fistulas.

KW - Arteriovenous fistula

KW - arteriovenous graft

KW - central vein stenosis

KW - internal jugular vein

KW - percutaneous transluminal angioplasty

UR - http://www.scopus.com/inward/record.url?scp=85059530083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059530083&partnerID=8YFLogxK

U2 - 10.1177/1129729818815327

DO - 10.1177/1129729818815327

M3 - Article

JO - Journal of Vascular Access

JF - Journal of Vascular Access

SN - 1129-7298

ER -